# NALOXONE HYDROCHLORIDE
> **ANDA207633** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2017-08-08
## Drug
- **FDA Application Number:** ANDA207633
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALOXONE HYDROCHLORIDE
- **Generic name:** NALOXONE HYDROCHLORIDE
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET THERAPS LLC
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2017-08-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207633)
---
*AI Analytics · CC0 1.0*